What is Euro-Med Laboratories Philippines Quick Ratio?
Euro-Med Laboratories PhilippinesPHS:EURO 82 Quick Ratio is 1.10 as of Mar. 2026, which is 21% above its 10-year median of 0.91. GuruFocus rates PHS:EURO with a GF Score™ of 82/100 and a GF Value™ of ₱1.02 (Fairly Valued). The stock has 4 warning signs investors should review. Among 994 Drug Manufacturers companies, Euro-Med Laboratories Philippines ranks worse than 62.37% on this metric.
PHS:EURO'
s Quick Ratio Range Over the Past 10 Years
Min: 0.76 Med: 0.91 Max: 1.22
Current: 1.1
During the past 13 years, Euro-Med Laboratories Philippines's highest Quick Ratio was 1.22. The lowest was 0.76. And the median was 0.91.
PHS:EURO's Quick Ratio is ranked worse than 62.37% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs PHS:EURO: 1.10
Euro-Med Laboratories Philippines (PHS:EURO) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Euro-Med Laboratories Philippines Quick Ratio Related Terms
Euro-Med Laboratories Philippines Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines Quick Ratio Chart
PHS:EURO vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's Quick Ratio falls into.
Euro-Med Laboratories Philippines Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines (PHS:EURO) has a Quick Ratio of 1.10 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Euro-Med Laboratories Philippines and its competitors. This is 21% above median its historical median of 0.91. Over the past decade, Euro-Med Laboratories Philippines' Quick Ratio has ranged from 0.76 to 1.22. According to the industry distribution chart, Euro-Med Laboratories Philippines ranks #620 out of 994 companies in the Drug Manufacturers industry, placing it in the top 62.4%.
Is Euro-Med Laboratories Philippines' Quick Ratio too high?
Euro-Med Laboratories Philippines' current Quick Ratio of 1.10 is 21% above median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.76 to a high of 1.22. The Drug Manufacturers industry median Quick Ratio is 1.45. Euro-Med Laboratories Philippines' value of 1.10 is 24.1% below this industry median. Based on the distribution chart, Euro-Med Laboratories Philippines ranks #620 out of 994 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Euro-Med Laboratories Philippines has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Euro-Med Laboratories Philippines' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Euro-Med Laboratories Philippines ranks #620 out of 994 companies for Quick Ratio. This places Euro-Med Laboratories Philippines in the lower half of its industry. The industry median Quick Ratio is 1.45. Euro-Med Laboratories Philippines' value of 1.10 is 24.1% below this benchmark. Historically, Euro-Med Laboratories Philippines' own Quick Ratio has ranged from 0.76 to 1.22 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 1.45, Euro-Med Laboratories Philippines has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Euro-Med Laboratories Philippines's current Quick Ratio of 1.10 is 24.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Euro-Med Laboratories Philippines and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Euro-Med Laboratories Philippines's current Quick Ratio is 1.10, which is 21% above median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euro-Med Laboratories Philippines stock overvalued right now?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines (PHS:EURO) is currently considered Fairly Valued. The stock's GF Value™ is ₱1.02, compared to a current price of ₱1.07 — trading 4.9% above its estimated fair value. The current Quick Ratio is 1.10, which is 21% above median its 10-year median of 0.91 and 24.1% below the Drug Manufacturers industry median of 1.45. Euro-Med Laboratories Philippines' overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Euro-Med Laboratories Philippines (PHS:EURO), the current Quick Ratio is 1.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Euro-Med Laboratories Philippines (PHS:EURO) Overvalued in 2026?
Based on GuruFocus' analysis, Euro-Med Laboratories Philippines stock appears to be overvalued.
The current stock price of ₱1.07 is trading 4.9% above its estimated GF Value™ of ₱1.02.
GuruFocus considers Euro-Med Laboratories Philippines to be Fairly Valued.
Key valuation signals for PHS:EURO:
Quick Ratio: 1.10 (21% above median its 10-year median of 0.91)
GF Value™: ₱1.02 vs. price of ₱1.07 (4.9% above fair value)
Industry Position: 24.1% below the Drug Manufacturers median (#620 of 994)
No single metric tells the full story. See the PHS:EURO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Euro-Med Laboratories Philippines Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small-volume parenterals and other solutions. The company also manufactures sterile water for injection, and other solutions such as ophthalmic, inhalation, irrigation, and dialysis. The Company also manufactures intravenous fluids in glass bottles, hemodialysis concentrates, ophthalmic products and disinfectants.
82GF Score
Get the complete analysis for PHS:EURO
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHS:EURO has been successfully added to your 
